Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0004 Transporter Info
Gene Name ABCG2
Transporter Name Breast cancer resistance protein
Gene ID
9429
UniProt ID
Q9UNQ0
Microbiota Influence of This DT (MBI)

Bacteria: Actinomycetota

   Genus: Bifidobacterium

     Bifidobacterium adolescentis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of ABCG2 expression in colon cancer condition [1]

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (Caco-2)

Detailed Description

 The Bifidobacterium adolescentis has been reported to decrease the expression of the drug transporter ABCG2.

     Bifidobacterium animalis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human ABCG2 substrates/drugs in the health condition [2]

Detailed Description

 The Bifidobacterium animalis subsp. lactis Bi-07 has been reported to sequester the drug Rosiglitazone, which limits the distribution of the drug in the body and its binding to the drug transporter ABCG2, thereby affecting the efficacy, safety, or bioavailability of the drug.

Bacteria: Bacillota

   Genus: Lacticaseibacillus

     Lacticaseibacillus casei 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human ABCG2 substrates/drugs in the health condition [2]

Detailed Description

 The Lacticaseibacillus casei Lpc-37 has been reported to sequester the drug Rosiglitazone, which limits the distribution of the drug in the body and its binding to the drug transporter ABCG2, thereby affecting the efficacy, safety, or bioavailability of the drug.

   Genus: Thomasclavelia

     Thomasclavelia ramosa 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human ABCG2 substrates/drugs in the health condition [2]

Detailed Description

 The Thomasclavelia ramosa 113-I has been reported to sequester the drug Rosiglitazone, which limits the distribution of the drug in the body and its binding to the drug transporter ABCG2, thereby affecting the efficacy, safety, or bioavailability of the drug.

Bacteria: Bacteroidota

   Genus: Bacteroides

     Bacteroides thetaiotaomicron 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human ABCG2 substrates/drugs in the health condition [2]

Detailed Description

 The Bacteroides thetaiotaomicron E50 has been reported to sequester the drug Rosiglitazone, which limits the distribution of the drug in the body and its binding to the drug transporter ABCG2, thereby affecting the efficacy, safety, or bioavailability of the drug.

Bacteria: Pseudomonadota

   Genus: Escherichia

     Escherichia coli 

Microbe Info

Click to Show/Hide the Full List 4 Microbe Influence Related to This Species      

       Microbe Influence 1

 Co-transport of human ABCG2 substrates/drugs in the health condition [3]

Regulating Factor
ompC

Detailed Description

 The protein ompC of Escherichia coli JM712 has been reported to transport similar substrates/drugs of ABCG2, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 2

 Co-transport of human ABCG2 substrates/drugs in the health condition [3]

Regulating Factor
ompF

Detailed Description

 The protein ompF of Escherichia coli JM712 has been reported to transport similar substrates/drugs of ABCG2, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 3

 Sequestration of human ABCG2 substrates/drugs in the health condition [4]

Detailed Description

 The Escherichia coli str. K-12 substr. MG1655 has been reported to sequester the drug Ciprofloxacin and Tetracycline, which limits the distribution of the drug in the body and its binding to the drug transporter ABCG2, thereby affecting the efficacy, safety, or bioavailability of the drug.

       Microbe Influence 4

 Down regulating of ABCG2 expression in colon cancer condition [1]

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (Caco-2)

Detailed Description

 The Escherichia coli Nissle 1917 has been reported to decrease the expression of the drug transporter ABCG2.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 8 Microbe Influence Related to This Species      

       Microbe Influence 1

 Inhibition of ABCG2 function in health condition [5]

Regulating Factor
Urolithin A

Studied Phenotype

 Health [ICD11: N.A]

Studied Tissue

 Kidney

In Vitro Model

 Madin-Darby canine kidney cells (MDCKII)

Detailed Description

 The metabolite urolithin a generated from the metabolism of ellagic acid and ellagitannins metabolites from gut host unspecified microbiota by the host unspecified microbiota has been reported to inhibit the function of the drug transporter ABCG2.

       Microbe Influence 2

 Inhibition of ABCG2 function in health condition [5]

Regulating Factor
Urolithin A glucuronide

Studied Phenotype

 Health [ICD11: N.A]

Studied Tissue

 Kidney

In Vitro Model

 Madin-Darby canine kidney cells (MDCKII)

Detailed Description

 The metabolite urolithin a glucuronide generated from the metabolism of ellagic acid and ellagitannins metabolites from gut host unspecified microbiota by the host unspecified microbiota has been reported to inhibit the function of the drug transporter ABCG2.

       Microbe Influence 3

 Inhibition of ABCG2 function in chronic kidney disease condition [6] , [7]

Regulating Factor
p-Cresol sulfate

Studied Phenotype

 Chronic kidney disease [ICD11: GB61]

Studied Tissue

 Kidney

In Vitro Model

 Human renal proximal tubule cells

Detailed Description

 The metabolite p-cresol sulfate generated from the metabolism of p-cresol by the host unspecified microbiota has been reported to inhibit the function of the drug transporter ABCG2.

       Microbe Influence 4

 Down regulating of ABCG2 expression in the health condition [8]

Regulating Factor
Urolithin A

Studied Tissue

 Colon

In Vivo Model

 NRGS mice

In Vitro Model

 Human colon carcinoma cells (HCT-116)

Detailed Description

 The metabolite urolithin a generated from the metabolism of dietary polyphenols by the host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCG2.

       Microbe Influence 5

 Down regulating of ABCG2 expression in colon cancer condition [9]

Regulating Factor
Chenodeoxycholic acid

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (T84)

Detailed Description

 The metabolite chenodeoxycholic acid generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCG2.

       Microbe Influence 6

 Up regulating of ABCG2 expression in colon cancer condition [9]

Regulating Factor
Deoxycholic acid

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (Caco-2)

Detailed Description

 The metabolite deoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCG2.

       Microbe Influence 7

 Up regulating of ABCG2 expression in hyperuricaemia condition [10]

Studied Phenotype

 Hyperuricaemia [ICD11: 5C55.Y]

Studied Tissue

 Kidney

In Vivo Model

 ICR specific-pathogen-free mice

Detailed Description

 The host unspecified microbiota has been reported to increase the expression of the drug transporter ABCG2.

       Microbe Influence 8

 Up regulating of ABCG2 expression in conventional mice compared with germ-free mice [11]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Liver

In Vivo Model

 C57BL/6N mice

Detailed Description

 The host unspecified microbiota has been reported to increase the expression of the drug transporter ABCG2.
References
1 Causative Role of Anoxic Environment in Bacterial Regulation of Human Intestinal Function. Cell Mol Bioeng. 2022 Sep 16;15(5):493-504.
2 Bioaccumulation of therapeutic drugs by human gut bacteria. Nature. 2021 Sep;597(7877):533-538.
3 The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli. J Antimicrob Chemother. 1993 Aug;32(2):195-213.
4 Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature. 2017 May 18;545(7654):299-304.
5 The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP). J Agric Food Chem. 2013 May 8;61(18):4352-9.
6 Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression. Toxins (Basel). 2018 Jul 19;10(7):300.
7 Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology. Toxicol In Vitro. 2015 Oct;29(7):1868-77.
8 Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis. Theranostics. 2022 Jul 18;12(12):5574-5595.
9 Gut Microbiota-Mediated Bile Acid Transformations Alter the Cellular Response to Multidrug Resistant Transporter Substrates in Vitro: Focus on P-glycoprotein. Mol Pharm. 2018 Dec 3;15(12):5711-5727.
10 The gut microbiota mediates the protective effects of anserine supplementation on hyperuricaemia and associated renal inflammation. Food Funct. 2021 Oct 4;12(19):9030-9042.
11 Effect of Intestinal Flora on Protein Expression of Drug-Metabolizing Enzymes and Transporters in the Liver and Kidney of Germ-Free and Antibiotics-Treated Mice. Mol Pharm. 2016 Aug 1;13(8):2691-701.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.